tiprankstipranks
Atrium Therapeutics, Inc. (RNA)
NASDAQ:RNA
US Market

Compare Atrium Therapeutics, Inc. (RNA) vs. Competitors

6 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Atrium Therapeutics, Inc.
$12.71
-3.29
-13.83%
1 Buy
0 Hold
0 Sell
Moderate Buy
PTC Therapeutics
$68.69
$5.69B
8.85
70.49%
9 Buy
4 Hold
0 Sell
Moderate Buy
Crispr Therapeutics AG
$51.22
$4.92B
-8.11
49.50%
12 Buy
3 Hold
1 Sell
Moderate Buy
Rhythm Pharmaceuticals
$84.39
$5.76B
45.93%
14 Buy
0 Hold
0 Sell
Strong Buy
Immunovant
$24.50
$4.99B
65.65%
10 Buy
2 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
RNA
Atrium Therapeutics, Inc.
12.71
-2.04
-13.83%
PTCT
PTC Therapeutics
68.69
23.61
52.37%
MRUS
CRSP
Crispr Therapeutics AG
51.22
12.41
31.98%
RYTM
Rhythm Pharmaceuticals
84.39
24.25
40.32%
IMVT
Immunovant
24.50
9.07
58.78%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts